Tag

Trans Women Health

Community Leaders Share Resources, Challenges at First Fenway Queer Women’s Health Roundtable

By | Fenway Health Newsroom, Fenway News, LGBT Health, Women's Health | One Comment
On Monday, December 5, Fenway Health’s Women’s Health team facilitated its first Queer Women’s Health Roundtable, an evening of open discussion of the issues that affect the health and wellbeing of queer, lesbian, bisexual, and transgender women and non-binary people assigned female at birth. Tanekwah Hinds, Women’s Health Program Coordinator, organized the roundtable to uplift and center the voices of community members speaking on behalf of the diverse populations that the Women’s Health Team serves. The representatives from each organization present were leaders who self-identified as cisgender women, transgender women, or non-binary individuals. “We wanted to provide a space for 
Read More

Shortage of Injectable Estrogen is a Public Health Crisis

By | Fenway Health Newsroom, Trans | One Comment
For nearly two years, drug manufacturers have not been able to meet demand for injectable estrogen, which is a commonly prescribed hormone therapy for transgender women. A policy brief released today by The Fenway Institute, Callen-Lorde Community Health Center, and Treatment Action Group (TAG) describes the shortage as a “public health crisis” and urges the U.S. Food and Drug Administration (FDA) to be more proactive in seeking to resolve the crisis. “Hormone therapy is life-saving for many transgender individuals and the current shortage of injectable estrogen violates transgender individuals’ right to comprehensive medical treatment that is free of discrimination,” said 
Read More

Injectable Estrogen Shortage Poses Major Health Concerns

By | Fenway Health Newsroom, Trans, Women's Health | No Comments
The United States is currently experiencing a severe shortage of injectable estrogen – a hormone treatment used by many transgender women and transfeminine people – that shows no signs of ending. National supplies of Delestrogen and its generic counterpart, Estradiol Valerate, dried up 18 months ago and have not since returned to market. Drug manufacturers estimate that the shortage will last at least until October, if not longer. The health fallout for transgender women in the absence of injectable estrogen could be devastating. Fenway Health, in collaboration with our community partners Callen-Lorde and Treatment Action Group, is seeking to bring 
Read More

What’s new with TransCEND? Find out this Thursday!

By | AIDS Action Committee, Community, Fenway Health Newsroom, HIV/AIDS, Trans, TransCEND | No Comments
On Thursday, July 27 TransCEND (Transgender Care and Education Needs Diversity) will hold a community meeting for anyone interested in learning more about services offered by TransCEND and the future of the program. AIDS Action Committee Executive Director Carl Sciortino and AIDS Action Transgender Health Coordinator Chastity Bowick will answer questions. Light refreshments will be served and attendees will receive a free gift! TransCEND provides support and risk reduction services to transgender women (male to female), who experience much higher rates of HIV than the general population. The program offers free HIV and STI testing and free risk reduction materials 
Read More

Study Finds Racial, Ethnic Disparities In Incarceration Of Trans Women

By | Fenway Health Newsroom, Research, The Fenway Institute, Trans, Women's Health | No Comments
A new study has found that high incarceration rates among transgender women disproportionally affect women of color, and these women frequently experience victimization and negative health factors while behind bars. The report, “Racial/Ethnic Disparities in History of Incarceration, Experiences of Victimization, and Associated Health Indicators Among Transgender Women in the U.S.,” was researched and authored by Sari Reisner, ScD, Research Scientist at The Fenway Institute; Jae Sevelius, PhD, of the UCSF Center of Excellence for Transgender Health; and Zinzi Bailey, ScD, Post-Doctoral Fellow at McGill University Institute of Health & Social Policy. The study documents racial and ethnic disparities in 
Read More